144
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Atypical antipsychotics as add-on treatment in late-life depression

&
Pages 1193-1198 | Published online: 09 Sep 2016

References

  • LenzeEJMulsantBHBlumbergerDMEfficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trialLancet2015386100112404241226423182
  • WhitefordHADegenhardtLRehmJGlobal burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010Lancet201338299041575158623993280
  • CooperCKatonaCLyketsosKA systematic review of treatments for refractory depression in older peopleAm J Psychiatry2011168768168821454919
  • HarmanJSMulsantBHKelleherKJSchulbergHCKupferDJReynoldsCFIIINarrowing the gap in treatment of depressionInt J Psychiatry Med200131323925311841122
  • SmagulaSFButtersMAAndersonSJAntidepressant response trajectories and associated clinical prognostic factors among older adultsJAMA Psychiatry201572101021102826288246
  • MulsantBHBlumbergerDMIsmailZRabheruKRapoportMJA systematic approach to pharmacotherapy for geriatric major depressionClin Geriatr Med201430351753425037293
  • MaustDTOslinDWThaseMEGoing beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical reviewAm J Geriatr Psychiatry2013211097398623567381
  • LenzeEJSheffrinMDriscollHCIncomplete response in late-life depression: getting to remissionDialogues Clin Neurosci200810441943019170399
  • RushAJStar-D: lessons learned and future implicationsDepress Anxiety201128752152421721070
  • AlexopoulosGSMeyersBSYoungRCCampbellSSilbersweigDCharlsonM‘Vascular depression’ hypothesisArch Gen Psychiatry199754109159229337771
  • KrishnanKRMcDonaldWMArteriosclerotic depressionMed Hypotheses19954421111157596303
  • BauerMDell’ossoLKasperSExtended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorderJ Affect Disord2013151120921923810357
  • RutherfordBSneedJMiyazakiMAn open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression augmentationInt J Geriatr Psychiatry2007221098699117340654
  • SheffrinMDriscollHCLenzeEJPilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remissionJ Clin Psychiatry200970220821319210951
  • CartaMGZairoFMellinoGHardoyMCAdd-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damageClin Pract Epidemiol Ment Health20072632818039392
  • TadgerSPaleacuDBarakYQuetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewArch Gerontol Geriatr201153110410520678815
  • ZhouXKeitnerGIQinBAtypical antipsychotic augmentation for treatment-resistant depression: a systematic review and network meta-analysisInt J Neuropsychopharmacol20151811pyv06026012350
  • YesavageJABrinkTLRoseTLDevelopment and validation of a geriatric depression screening scale: a preliminary reportJ Psychiat Res198317137497183759
  • FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
  • LingjaerdeOAhlforsUGBechPDenckerSJElgenKThe UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patientsActa Psychiatr Scand Suppl198733411002887090
  • PapakostasGISheltonRCSmithJFavaMAugmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysisJ Clin Psychiatry200768682683117592905
  • TadgerSPaleacuDBarakYQuetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewArch Gerontol Geriatr201153110410520678815
  • MadhusoodananSBrennerRAlcantraAClinical experience with quetiapine in elderly patients with psychotic disordersJ Geriatr Psychiatry Neurol2000131283210753004
  • TariotPNSalzmanCYeungPPPultzJRakIWLong-term use of quetiapine in elderly patients with psychotic disordersClin Ther20002291068108411048905
  • SchneiderLSDagermanKSInselPRisk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo controlled trialsJAMA2005294151934194316234500
  • GillSSBronskillSENormandSLAntipsychotic drug use and mortality in older adults with dementiaAnn Intern Med20071461177578617548409
  • NewcomerJWMetabolic considerations in the use of antipsychotic medications: a review of recent evidenceJ Clin Psychiatry200768Suppl 1202717286524
  • ZhengLMackWJDagermanKSMetabolic changes associated with second-generation antipsychotic use in Alzheimer’s disease patients: the CATIE-AD studyAm J Psychiatry2009166558359019369318
  • SheikhJIYesavageJAGeriatric Depression Scale (GDS): recent evidence and development of a shorter versionBrinkTLClinical Gerontology: A Guide to Assessment and InterventionNew York, NYThe Haworth Press1986165173
  • ScoginFThe concurrent validity of the Geriatric Depression Scale with depressed older adultsClin Gerontologist1987712331
  • JesteDVBlazerDCaseyDACNP white paper: update on use of antipsychotic drugs in elderly persons with dementiaNeuropsychopharmacology200733595797017637610
  • FDA. Public Health AdvisoryDeaths with antipsychotics in elderly patients with behavioral disturbances2010 Available from: www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsand-providers/ucm053171Accessed May 1, 2016